title: Preclinical toxicology and biodistribution studies of recombinant adeno-associated virus 1 human acid α-glucosidase.
abstract: A biodistribution and toxicology study was performed to test the acute toxicities of intradiaphragmatic injection of a recombinant adeno-associated virus (rAAV) 2/1-human acid alpha-Glucosidase (hGAA) driven by a cytomegalovirus (CMV) promoter (rAAV1-CMV-hGAA) in New Zealand white rabbits and in the rodent Pompe disease model by injecting at the right quadriceps. Studies performed using fluoroscopy and AAV2-GFP demonstrated spread upon intradiaphragmatic injection, and the ability of AAV to infect and express acid α-glucosidase (GAA) throughout the diaphragm. For the preclinical study, 10 rabbits (5 male, 5 female) were divided into two groups, vehicle control (Lactated Ringer's) and test article (1.5×10(12) vector genomes [vg] rAAV1-CMV-hGAA), and euthanized on day 21. After direct visualization, the left hemidiaphragm was injected at three locations. There was up to a 2,500-fold increase in circulating anti-AAV1 antibodies directed to the vector capsids. In addition, up to an 18-fold increase in antibodies against the GAA protein was generated. Injection sites maintained up to 1.0×10(5) vg/μg genomic DNA (gDNA), while uninjected sites had up to 1.0×10(4) vg/μg gDNA. Vector DNA was present in blood at 24 hr postinjection at up to 1.0×10(6) vg/μg gDNA, followed by a decrease to 1.0×10(3) vg/μg gDNA at euthanization on day 21. Nominal amounts of vector DNA were present in peripheral organs, including the brain, spinal cord, gonads, and skeletal muscle. Upon histopathological examination, fibroplasias of the serosal surface were noted at diaphragm injections sites of both groups. In addition, an increase in mononuclear cell infiltration in the diaphragm and esophagus in vector-dosed animals was found. Elevated creatine phosphokinase levels, an indicator of muscle repair, was observed in all animals postprocedure but persisted in vector-injected rabbits until euthanization. A follow-up study suggested that this was directed against the human transgene expression in a foreign species. Overall, this study demonstrates diffusion of vector throughout the diaphragm after localized injections.
authors.affiliation: 1 Department of Pediatrics, University of Florida College of Medicine , Gainesville, FL, 32610.
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Conlon
authors.forename: Kirsten
authors.initials: K
authors.lastname: Erger
authors.forename: Stacy
authors.initials: S
authors.lastname: Porvasnik
authors.forename: Travis
authors.initials: T
authors.lastname: Cossette
authors.forename: Cheryl
authors.initials: C
authors.lastname: Roberts
authors.forename: Lynn
authors.initials: L
authors.lastname: Combee
authors.forename: Saleem
authors.initials: S
authors.lastname: Islam
authors.forename: Jeffry
authors.initials: J
authors.lastname: Kelley
authors.forename: Denise
authors.initials: D
authors.lastname: Cloutier
authors.forename: Nathalie
authors.initials: N
authors.lastname: Clément
authors.forename: Corinne R
authors.initials: CR
authors.lastname: Abernathy
authors.forename: Barry J
authors.initials: BJ
authors.lastname: Byrne
mesh_terms: D000818:Animals; D000229:Dependovirus / Q000235:genetics* / Q000378:metabolism; D005260:Female; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D006009:Glycogen Storage Disease Type II / Q000628:therapy*; D006801:Humans; D008297:Male; D011817:Rabbits; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D000520:alpha-Glucosidases / Q000235:genetics* / Q000378:metabolism
chemical_list: D011994:Recombinant Proteins; C509951:GAA protein, human; D000520:alpha-Glucosidases
references.citation: J Biol Chem. 1998 Jul 24;273(30):19086-92
references.pmid: 9668092
references.citation: Curr Mol Med. 2002 Mar;2(2):145-66
references.pmid: 11949932
references.citation: Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16363-8
references.pmid: 19706466
references.citation: FASEB J. 2013 Jan;27(1):34-44
references.pmid: 22993195
references.citation: Mol Ther. 2002 May;5(5 Pt 1):571-8
references.pmid: 11991748
references.citation: Genet Med. 2006 May;8(5):267-88
references.pmid: 16702877
references.citation: J Gene Med. 2013 Feb;15(2):65-77
references.pmid: 23355455
references.citation: Hum Mol Genet. 2011 Apr 15;20(R1):R61-8
references.pmid: 21518733
references.citation: Ann Neurol. 2009 Sep;66(3):290-7
references.pmid: 19798725
references.citation: Mol Genet Metab. 2010 Jan;99(1):26-33
references.pmid: 19775921
references.citation: Mol Ther. 2002 Sep;6(3):329-35
references.pmid: 12231168
references.citation: Methods Enzymol. 2002;346:413-30
references.pmid: 11883083
references.citation: BMC Surg. 2008 Apr 12;8:7
references.pmid: 18405386
references.citation: Genet Med. 2009 Mar;11(3):210-9
references.pmid: 19287243
references.citation: N Engl J Med. 2009 Aug 13;361(7):725-7
references.pmid: 19675341
references.citation: Mol Ther. 2010 Mar;18(3):502-10
references.pmid: 20104213
references.citation: Mol Ther. 2007 Mar;15(3):501-7
references.pmid: 17245350
references.citation: Mol Genet Metab. 2003 Sep-Oct;80(1-2):159-69
references.pmid: 14567965
references.citation: Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9419-24
references.pmid: 19474295
references.citation: Hum Gene Ther. 2007 Mar;18(3):245-56
references.pmid: 17376008
references.citation: Surg Laparosc Endosc Percutan Tech. 2008 Jun;18(3):280-2
references.pmid: 18574416
references.citation: Hum Gene Ther. 2006 Dec;17(12):1177-86
references.pmid: 17115945
references.citation: Mol Ther. 2001 Sep;4(3):217-22
references.pmid: 11545612
references.citation: Methods Mol Biol. 2008;437:51-91
references.pmid: 18369962
references.citation: Hum Gene Ther. 2005 May;16(5):551-7
references.pmid: 15916480